Beyond cancer, leptin may play a role in other diseases associated with inflammation: In non-alcoholic fatty liver disease, leptin activates hepatic stellate cells (Ito cells), leading to upregulation of pro-inflammatory and pro-angiogenic effects, acting as an inducer of hepatic fibrogenesis (Francisco et al., 2018). This evidence concerns the gene LEP and metabolic dysfunction-associated steatotic liver disease.